Masaaki Korenaga, Kazumoto Murata, Namiki Izumi, Nobuharu Tamaki, Osamu Yokosuka, Tetsuo Takehara, Naoya Sakamoto, Goki Suda, Shuhei Nishiguchi, Hirayuki Enomoto, et al. No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy. Global health & medicine. 2022. 4. 4. 216-224
Kaneko T, Kanda T, Nirei K, Matsumoto N, Yamazaki M, Shibata T, Tamura A, Ogawa M, Nakajima N, Matsuoka S, et al. Follow-up Results of HCV GT2 Patients after Sofosbuvir/Ribavirin Therapy: Careful Attention to Occurrence of HCC. Anticancer Res. 2019. 39. 7. 3855-3862
KOINUMA masayoshi, Shinichiro Suzuki, Tsuyoshi Hoshino, Takashi Kawaguchi, Yuki Sasaki, Susumu Otsuka, Yoshikazu Yoshida, Kazushige Nirei, Mitsuhiko Moriyama, Hitoshi Nakamura. Prediction of the Lowest Level of Thrombocytopenia to Avoid Thrombocytopenia-related Treament Discontinuation in PEG-IFNα-2b/RBV Combination Therapy. Japanese Society of Pharmaceutical Health Care and Sciences. 2012. 38. 1. 43-50